Global acceptance of COVID-19 vaccine among persons with diabetes: A systematic review and meta-analysis.
Diabetes Res Clin Pract
; 201: 110731, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2327793
ABSTRACT
AIM:
This review aimed to estimate the level of acceptance of COVID-19 vaccine among persons with diabetes.METHODS:
A systematic search was conducted on PubMed, MEDLINE, Embase, and CINAHL to identify relevant studies for this review. A random-effects meta-analysis was performed to generate an overall estimate of vaccine acceptance. The I2 statistic was used to quantify the degree of variation across studies, and subgroup analysis was conducted to identify the sources of heterogeneity. The review was conducted in line with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA).RESULTS:
This review included 18 studies involving 11,292 diabetes patients. The pooled prevalence of COVID-19 vaccine acceptance among persons with diabetes was 76.1% (95% CI 66.7%-83.5%). The pooled prevalence across the continent ranged from 68.9% (95% CI 47.8%-84.3%) in Asia to 82.1% (95% CI 80.2%-83.8%) in Europe. Barriers to vaccine acceptance included misinformation, lack of information, mistrust, health concerns, and external influences.CONCLUSION:
The barriers to vaccine acceptance identified in this review, could inform the formulation of health policies and public health interventions that are specifically tailored to address the needs of persons with diabetes.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Diabetes Mellitus
/
COVID-19
Tipo de estudio:
Estudio observacional
/
Ensayo controlado aleatorizado
/
Revisiones
/
Revisión sistemática/Meta análisis
Tópicos:
Vacunas
Límite:
Humanos
País/Región como asunto:
Asia
/
Europa
Idioma:
Inglés
Revista:
Diabetes Res Clin Pract
Asunto de la revista:
Endocrinologia
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS